The $10M figure seems very high. I'll grant that drug trials are quite expensive.
Lacking the need to work under an FDA paradigm, the basis of your conjecture is based upon what? What scope of trial do you envision that would consume $10M of resources?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.